AIdoc

AIdoc

Private
Tel Aviv, Tel Aviv DistrictHealthcare & Life Scienceshttps://www.aidoc.com/

Last Round

Series E

4/29/2026

Total Funding Raised

$560M

Company Overview

AIdoc is a healthcare technology company that develops AI-powered solutions for medical imaging analysis. Its platform assists radiologists and other physicians by automatically detecting and triaging acute abnormalities in medical scans, such as CTs. The 'Always-on AI' runs in the background to analyze medical imaging data, flag urgent findings like intracranial hemorrhages and pulmonary embolisms, and streamline the diagnostic workflow. The company's goal is to improve patient outcomes, enhance diagnostic accuracy, and increase efficiency for healthcare providers. AIdoc's solutions have received numerous FDA clearances and are used in over 1,000 medical centers worldwide.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, ML Platforms

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

medical imaging AIradiology AIAI triageclinical decision supportAI operating systemabnormality detectionradiology copilotstroke detection AIpulmonary embolism detectionFDA cleared AIcase prioritizationdiagnostic AIclinical workflow integrationPACS integrationclinical foundation modelEHR integrationpay-per-scan

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AIdoc Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AIdoc Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series E4/29/2026
Growth Equity7/23/2025
Strategic1/21/2025
Series D Extension11/27/2023
Series D6/16/2022
Series C
7/13/2021

Key People

Founding team and executive leadership

Gal Yaniv

Co-Founder And Chief Medical Officer

Founding Team

Elad Walach

CEO

Executive Team

Michael B. Braginsky

CTO

Executive Team

Arvind Kadaba

Chief Financial Officer

Executive Team

AIdoc Investors

Notable investors and investment history

InvestorRounds
SoftBank Investment AdvisersSeries E
EmergeSeries A, Series B
TCVGrowth Equity, Series D
Jibe VenturesGrowth Equity, Series C
Magma Venture PartnersSeries C, Series A, Series B, Series D, Growth Equity
NVenturesGrowth Equity
Alpha Intelligence CapitalGrowth Equity, Series C, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2026

    $150M round led by Goldman Sachs Alternatives

  • Apr 21, 2026

    Partnered with Sol Radiology to serve Southern California facilities.

AIdoc Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AIdoc Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AIdoc's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv, Tel Aviv District
Employee Range546
Year Founded2016
Last Funding4/29/2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.